Literature DB >> 2871381

Fetal neuronal grafts in monkeys given methylphenyltetrahydropyridine.

D E Redmond, J R Sladek, R H Roth, T J Collier, J D Elsworth, A Y Deutch, S Haber.   

Abstract

Fetal substantia nigra cells of two different gestational ages were successfully transplanted into the brains of three methylphenyltetrahydropyridine-treated monkeys with severe parkinsonian motor and behavioural deficits. Functional improvement continued for 10 weeks after cell grafts into the striata of two monkeys with substantial numbers of tyrosine-hydroxylase-positive fetal neurons at necropsy. Behavioural improvement was correlated with increases in cerebrospinal fluid (CSF) homovanillic acid (HVA) concentrations after the transplants. A control monkey with inappropriately placed transplanted cells of an earlier gestational age remained severely parkinsonian and died during a similar period. CSF HVA fell slightly in this monkey from the low level seen before the transplants. Fetal dopamine neurons of two different gestational ages appear to survive transplantation in primates and have biochemical and functional effects.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2871381     DOI: 10.1016/s0140-6736(86)91839-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  37 in total

1.  Of monkeys and men: vervets and the genetics of human-like behaviors.

Authors:  R M Palmour; J Mulligan; J J Howbert; F Ervin
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

2.  Proceedings: cell therapies for Parkinson's disease from discovery to clinic.

Authors:  Rosa Canet-Aviles; Geoffrey P Lomax; Ellen G Feigal; Catherine Priest
Journal:  Stem Cells Transl Med       Date:  2014-08-22       Impact factor: 6.940

3.  Large animal models are critical for rationally advancing regenerative therapies.

Authors:  Dustin R Wakeman; Andrew M Crain; Evan Y Snyder
Journal:  Regen Med       Date:  2006-07       Impact factor: 3.806

4.  Aged monkeys as a partial model for Parkinson's disease.

Authors:  P J Hurley; J D Elsworth; M C Whittaker; R H Roth; D E Redmond
Journal:  Pharmacol Biochem Behav       Date:  2011-05-18       Impact factor: 3.533

Review 5.  Emerging regenerative medicine and tissue engineering strategies for Parkinson's disease.

Authors:  James P Harris; Justin C Burrell; Laura A Struzyna; H Isaac Chen; Mijail D Serruya; John A Wolf; John E Duda; D Kacy Cullen
Journal:  NPJ Parkinsons Dis       Date:  2020-01-08

Review 6.  Fetal stem cell transplantation: Past, present, and future.

Authors:  Tetsuya Ishii; Koji Eto
Journal:  World J Stem Cells       Date:  2014-09-26       Impact factor: 5.326

7.  Intracerebral xenografts of human mesencephalic tissue into athymic rats: immunochemical and in vivo electrochemical studies.

Authors:  I Strömberg; P Almqvist; M Bygdeman; T E Finger; G Gerhardt; A C Granholm; T J Mahalik; A Seiger; B Hoffer; L Olson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

8.  Comparison of adrenal and foetal nigral grafts on drug-induced rotation in rats with 6-OHDA lesions.

Authors:  V J Brown; S B Dunnett
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

9.  MPTP induced hemiparkinsonism in monkeys: behavioral, mechanographic, electromyographic and immunohistochemical studies.

Authors:  A Benazzouz; C Gross; J Dupont; B Bioulac
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

10.  Cholinergic neural transplants into hippocampus restore learning ability in monkeys with fornix transections.

Authors:  R M Ridley; H D Thornley; H F Baker; A Fine
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.